Thomas P. Slavin, M.D., Named Chief Medical Officer for Myriad Genetics
Go back to Thomas P. Slavin, M.D., Named Chief Medical Officer for Myriad Genetics| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.19 +0.14 (4.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.05 | 52 Week High | $45.34 | |||
| Open | $3.06 | 52 Week Low | $15.92 | |||
| Day High | $3.21 | P/E | 1.37 | |||
| Day Low | $3.01 | EPS | $2.33 | |||
| Volume | 1,756,389 | |||||
